Andrew McDonald

Dr. McDonald co-founded Attune and has served as CEO since inception. He is also CEO and a Founding Partner of LifeSci Partners, an investor relations and advisory firm specializing in the life sciences. Previously, Dr. McDonald served as senior biotechnology analyst at Great Point Partners and was the Head of Healthcare Research and a Biotechnology Analyst at ThinkEquity Partners. Prior to entering the financial services, Andrew was a senior medicinal chemist Pfizer and Cytokinetics, where he discovered and developed small molecule anti-cancer therapeutics. Andrew received a Ph.D. in organic chemistry from UC Irvine and completed his B.S. in chemistry at UC Berkeley.